Cargando…
Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
BACKGROUND: The incidence of p16+ oropharyngeal squamous cell carcinoma (OPSCC) has been increasing. The notion that p16+ OPSCC has a propensity for atypical and disseminating metastasis has gained traction. We compared treatment failure patterns in p16+ and p16− OPSCC and evaluated survival impact....
Autores principales: | Hamill, Chelsea S., Muller, Richard Grant, Clancy, Kate, Vu, Brandon, Gui, Shanying, Thuener, Jason Eric, Wasman, Jay, Li, Shawn, Fowler, Nicole, Rezaee, Rod, Lavertu, Pierre, Teknos, Theodoros N., Pan, Quintin, O'Neill, Wendi Quinn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392389/ https://www.ncbi.nlm.nih.gov/pubmed/36000056 http://dx.doi.org/10.1002/lio2.779 |
Ejemplares similares
-
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
por: Clancy, Kate, et al.
Publicado: (2021) -
Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
por: Saito, Yuki, et al.
Publicado: (2016) -
The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications
por: Hussain, Timon, et al.
Publicado: (2022) -
Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
por: Weiss, Bernhard G., et al.
Publicado: (2020) -
Clinical impact of p16 positivity in nasopharyngeal carcinoma
por: Shimizu, Yuri, et al.
Publicado: (2022)